TL;DR
- Roughly 27% of people with ADHD will develop cannabis use disorder in their lifetime — nearly three times the general population rate, per a 2024 meta-analysis in the Journal of Psychiatric Research.
- Cannabis is not simply “not working.” Research suggests it genuinely eases some ADHD experiences — impulsivity, restlessness, mental frustration — while measurably worsening the two things your teen most needs for school and work: sustained attention and memory.
- Canadian cannabis is roughly five times stronger than it was twenty years ago. The average THC content in legal dried flower is now around 20%, up from about 4% in the early 2000s.
- The good news is real: a randomized trial published in late 2025 found that four weeks of abstinence brought adolescents’ inhibitory control measurably closer to that of non-using peers. Memory gains in earlier work showed up in the first week.
- Withdrawal is common (about 47% of regular users) and sleep is usually the hardest part — which matters, because sleep problems are what drove a lot of ADHD teens to cannabis in the first place.
- Arguing about whether cannabis “works” is a losing conversation. Asking what job it’s doing is not.
Why does cannabis feel like it works for ADHD?
Because for some symptoms, it does — briefly. That’s the part parents tend to skip, and skipping it is why these conversations fail.
Hernandez and Levin, writing in Psychiatric Clinics of North America, found that people with ADHD who use cannabis most often describe therapeutic motives: sleep, physical pain, and the relentless internal noise. These aren’t excuses invented on the spot. They’re the actual reported reasons, and they line up with what we know about ADHD.
A 2026 study in the Journal of Attention Disorders by Ryan and colleagues put a finer point on it. In a community sample of adults with ADHD, participants reported that cannabis improved impulsivity and mental frustration — and worsened inattention and memory. That’s not a wash. That’s a trade.
Here’s the trade in plain terms: cannabis takes the edge off the symptoms your teen feels and dulls the capacities their teacher, coach, and employer see. The relief is subjective and immediate. The cost is objective and delayed. Which is exactly the shape of every trap an ADHD brain is poorly equipped to notice, because noticing it requires the very time-horizon thinking that ADHD compromises.
Cannabis doesn’t eliminate the difficulty of having ADHD. It relocates it — from tonight into next Tuesday.
I call this borrowed relief. The regulation your teen feels at 9 p.m. isn’t generated; it’s withdrawn against tomorrow’s executive function, and the loan carries interest. For a while the payments are manageable. Then they aren’t, and the only apparent solution to falling behind is another withdrawal.
How common is cannabis use disorder in people with ADHD?
About one in four people with ADHD develops cannabis use disorder at some point. Froude and colleagues, in a 2024 meta-analysis of fourteen studies, found a lifetime prevalence of 26.9% and current prevalence of 19.2% among ADHD populations. Compared to people without ADHD, the risk was roughly 2.85 times higher for lifetime diagnosis.
Those prediction intervals were wide — lifetime estimates ranged from 12.4% to 48.8% across studies — which is worth saying plainly rather than rounding away. The signal is unmistakable. The precision is not.
What this means practically: if your teen has ADHD and is using cannabis regularly, you are not being paranoid. You’re looking at a population where this particular door swings open much more easily.
Is my teen’s cannabis use actually a problem, or am I overreacting?
The most useful question isn’t how much they use. It’s what happens when they try to stop.
Frequency alone is a poor diagnostic. Plenty of adults use cannabis weekly without meaningful impairment. What distinguishes problematic use is the pattern around it:
- They’ve tried to cut back and couldn’t, or they’ve never tried and get visibly agitated at the suggestion.
- Use has migrated earlier in the day — from evening, to after school, to before school.
- Activities that used to matter have quietly dropped off the schedule. Sports, friends who don’t use, the part-time job.
- Sleep only happens with it.
- Tolerance has climbed. What worked six months ago doesn’t.
- They’re defensive in a way that feels disproportionate — which, to be fair, is also just being seventeen.
That last one deserves care. Defensiveness isn’t proof of a disorder. But defensiveness combined with the other markers usually means the substance has become load-bearing.
What does the research actually say about cannabis as ADHD treatment?
There is no credible evidence supporting cannabis as a treatment for core ADHD symptoms, and that’s a stronger statement than “we don’t know yet.”
A scoping review in the Journal of Psychiatric Research concluded that while some studies reported improvement, most found cannabis either worsened ADHD symptoms or had no effect, and that cannabis is not recommended for people with ADHD. Randomized controlled trials using standardized THC:CBD preparations have not demonstrated significant improvement in core symptoms.
This matters for the conversation at home, because your teen may have encountered a genuinely persuasive version of the opposite claim online. The honest response isn’t “that’s nonsense.” It’s: the people who study this have looked, repeatedly, and the benefit doesn’t hold up when you measure it instead of asking about it.
Which raises an uncomfortable but useful question worth putting to a young person directly: if it’s treatment, what are we treating, and how would we know if it stopped working?
Is today’s cannabis different from what I might have tried?
Yes, and this is one of the few places where the parental “back in my day” instinct is empirically correct.
A 2025 article in the Canadian Medical Association Journal by Li, Solmi, Myran, and Fabiano reported that THC content in Canadian cannabis has roughly quintupled over twenty years — from about 4% in the early 2000s to around 20% in most legal dried flower. Concentrates and vape products go considerably higher. Health Canada flags concentrations above 20% as significantly raising the risk of long-term mental health effects.
The same review found elevated psychosis risk associated with high-potency products (above 10% THC), frequent use, younger age, and male sex, with a dose-response relationship.
On the population level, Myran and colleagues tracked 13.5 million Ontario residents in JAMA Network Open and found that the proportion of new schizophrenia diagnoses attributable to cannabis use disorder rose from 3.7% before legalization to 10.3% after — with the sharpest increase among men aged 19 to 24. Hospital care for cannabis use disorder in Ontario rose 270% over the same span.
The researchers themselves are careful here, and so am I: observational data of this kind cannot establish that cannabis causes schizophrenia. What it does establish is that the population-level burden is climbing, that young men are carrying most of it, and that the products driving it are the ones currently on the shelf.
For Saskatchewan families, that shelf is a fifteen-minute drive and a legal purchase for anyone nineteen and over. This isn’t a lecture about legalization. It’s a note that “it’s legal” and “it’s the same substance you knew” are two different claims, and only the first one is true.
What actually improves if they stop?
Inhibitory control and memory — and faster than most people expect.
This is the part of the conversation that shouldn’t be delivered as a threat, because it’s genuinely encouraging.
Schuster and colleagues at Massachusetts General, publishing in the Journal of Clinical Psychiatry, found that one month of abstinence in adolescents and young adults produced measurable improvement in the ability to learn and recall new information — and most of that gain appeared during the first week. No such improvement occurred in those who continued using.
Their larger randomized trial, published in Frontiers in Psychiatry in December 2025, enrolled 238 adolescents aged 13 to 19. Those randomized to incentivized abstinence showed greater improvement in inhibitory control over four weeks than those who continued their usual use. At week four, the abstinent group’s performance was similar to that of adolescents who had never used.
Read that last sentence again, because it’s the one to hand your teen: four weeks, and the gap closed.
Some of what cannabis takes, it gives back. But it only gives it back to people who stop long enough to collect.
Attention, notably, did not improve in the earlier study — which is a useful piece of honesty. Quitting cannabis does not treat ADHD. It removes a layer that was sitting on top of it. The ADHD underneath still needs its own plan.
Why is stopping so hard, and what should we expect?
Expect withdrawal, expect sleep to be the worst of it, and expect week one to be misleading.
A meta-analysis by Bahji and colleagues in JAMA Network Open, covering more than 23,000 participants, found cannabis withdrawal syndrome in about 47% of people with regular or dependent use. Rates were higher among daily users and those using tobacco or other substances alongside it.
The common features are irritability, anger, anxiety, restlessness, appetite loss, unsettling dreams, and — most disruptive of all — insomnia. Sleep difficulty is consistently the symptom most likely to send someone back.
Here’s the trap that makes this so hard for ADHD teens specifically. Many started using because sleep was already broken. ADHD carries elevated rates of insomnia, delayed sleep phase, and general sleep disturbance. Cannabis helps with sleep onset in the short term, then tolerance builds and sleep architecture degrades. Now stopping produces insomnia that is worse than the original problem — and the person experiencing it has every reason to conclude that cannabis was helping after all.
It wasn’t. But you cannot win that argument with someone who hasn’t slept in four days.
This is why sleep intervention shouldn’t wait until after the cannabis is gone. Cognitive behavioural therapy for insomnia can be started while someone is still using, and it addresses the thing that will otherwise pull them back. If sleep is the load-bearing wall, don’t knock it out and hope.
What treatment approaches have evidence behind them?
Motivational enhancement plus CBT is the front-line psychosocial treatment, and adding contingency management improves abstinence rates further.
A systematic review and meta-analysis of psychosocial interventions for cannabis use disorder found that CBT combined with motivational enhancement substantially increased point abstinence and continuous abstinence compared to inactive comparators. Dialectical behavioural and acceptance-based approaches also increased point abstinence.
Contingency management — structured, reliable reinforcement for verified non-use — has moderate-to-high quality evidence supporting it, per a 2024 meta-analysis in European Addiction Research covering sixteen studies in adults and adolescents. In adolescent trials, adding contingency management to MET/CBT produced greater abstinence during treatment than MET/CBT alone.
Worth flagging one honest finding from the same body of research: CBT-based approaches, while effective for abstinence, showed reduced treatment completion. People drop out. Retention is its own problem, and any plan that doesn’t account for it is a plan on paper.
And a caution about medication expectations. In adolescents with ADHD and predominantly cannabis-related substance use, methylphenidate trials have improved ADHD symptoms and global functioning without reducing substance use. Treating the ADHD properly is necessary. It is not sufficient. Two problems, two treatments.
How do I raise this without blowing up the relationship?
Lead with curiosity about the function, not judgment about the substance.
The single most common failure I see is a parent opening with the harm data. It’s accurate, it’s important, and it lands as an attack — which triggers exactly the defensive crouch that ends the conversation.
What works better:
Ask what it does. Not rhetorically. Actually ask. “What’s it like right before you use, compared to twenty minutes after?” You’ll learn whether you’re dealing with sleep, anxiety, boredom, social pressure, or emotional overwhelm — and those require different responses.
Ask what they don’t like about it. Almost every regular user has a private list. Cost. Cough. Fogginess. Having to plan around it. Inviting that list into the open is more persuasive than anything you could add to it.
Propose an experiment, not a verdict. “Three days off, just so we both know what we’re working with” is a proposal someone can accept without conceding anything. A demand for abstinence is a proposal they have to lose in order to accept.
Name the trade rather than the danger. “I think it helps with the racing and hurts the remembering, and I want to know if you notice that too” invites data. “This is destroying your brain” invites eye-rolling.
Say the thing about relief out loud. Something like: I believe you that it helps. That’s exactly why I’m worried — because things that help are hard to put down, and I’d rather you have something that helps without a bill attached. This is the sentence that keeps you in the room.
Expect this to be many conversations. One good talk does not resolve this. What one good talk does is establish that you’re a person who can be told the truth.
What if they refuse to stop?
Then your goal shifts from cessation to keeping the door open, and that is a legitimate clinical goal, not a surrender.
Practical positions worth holding even without agreement:
- No driving after use, without exception, no negotiation, and a guaranteed no-questions ride home. In rural Saskatchewan, where the alternative to driving is often nothing, this one matters more than it does in a city.
- Keep the ADHD treated. Untreated ADHD is a standing motive to self-medicate.
- Keep the sleep work going regardless of use status.
- Preserve at least one non-using domain — a sport, a job, a friend group. When everything a young person does happens with the same substance present, quitting means losing their whole life at once.
- Stay in contact. Young people who are still talking to a parent have a route back. Young people who have been cut off have a route further in.
If there are signs of paranoia, hearing or seeing things others don’t, persistent confusion, or a sudden withdrawal from reality, that’s not a “wait and see” — that’s a same-day medical contact. Clinicians in Canada are reporting more youth presenting with high-potency-related psychotic symptoms that are taking longer to clear, even after use stops.
Frequently asked questions
Does cannabis help ADHD? There’s no evidence supporting cannabis as an effective treatment for core ADHD symptoms. Users commonly report improvement in impulsivity, restlessness, and mental frustration, alongside worsening of inattention and memory. Reviews of the literature conclude cannabis is not recommended for people with ADHD.
How long does cannabis withdrawal last? Most symptoms peak within the first week and substantially settle within two to three weeks. Sleep disturbance and unusual dreams tend to persist longest and are the most common reason people return to use.
Will my teen’s memory and focus recover if they quit? Partly, and reasonably quickly. Research has shown memory improvement within the first week of abstinence and improved inhibitory control after four weeks, reaching levels comparable to non-using peers. Attention has been less responsive — because quitting cannabis doesn’t treat the underlying ADHD.
Is CBD the same concern as THC? No. The psychosis, cognitive, and dependence findings discussed here relate to THC, particularly high-concentration products. CBD carries a different profile, though evidence for CBD in ADHD is also lacking.
My teen only uses at night to sleep. Is that safer? It’s the most common pattern and among the hardest to interrupt, because it’s genuinely doing a job. Tolerance builds, sleep quality degrades over time, and stopping produces rebound insomnia worse than the original problem. Sleep-focused treatment is usually the necessary first move rather than the last.
Should I search their room? Rarely productive as a first step, and it costs you the thing you most need — their willingness to tell you the truth. Safety concerns (driving, psychotic symptoms, other substances) change that calculus.
Where do I start in Saskatchewan? Family physician or nurse practitioner for an ADHD treatment review and referral, and a counsellor with training in motivational interviewing and adolescent substance use. If cannabis use has been daily and prolonged, ask specifically about withdrawal support and sleep intervention as part of the plan.
A closing note for parents
The teenager saying it’s the only thing that helps is telling you something true. Something helps them. That’s worth knowing, and it’s worth taking seriously rather than correcting.
The work isn’t proving them wrong. It’s making that sentence untrue — by building enough other things that help that cannabis stops being the only one.
That takes a treated ADHD, a functioning sleep system, some tolerable way to sit with discomfort, and at least one part of life that feels good sober. It takes longer than anyone wants. And it works considerably more often than the version where a parent wins the argument.
This article is for educational purposes and does not constitute medical advice, diagnosis, or treatment. Cannabis use disorder, ADHD, and co-occurring sleep and mood conditions require individual assessment by a qualified health professional. If you’re concerned about a young person’s substance use or mental health, please consult your family physician, nurse practitioner, or a registered mental health clinician.
References
Bahji, A., Stephenson, C., Tyo, R., Hawken, E. R., & Seitz, D. P. (2020). Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: A systematic review and meta-analysis. JAMA Network Open, 3(4), e202370. https://doi.org/10.1001/jamanetworkopen.2020.2370
Froude, A. M., Fawcett, E. J., Coles, A., Drakes, D. H., Harris, N., & Fawcett, J. M. (2024). The prevalence of cannabis use disorder in attention-deficit hyperactivity disorder: A clinical epidemiological meta-analysis. Journal of Psychiatric Research, 172, 391–401. https://doi.org/10.1016/j.jpsychires.2024.02.050
Hernandez, M., & Levin, F. R. (2022). Attention-deficit hyperactivity disorder and therapeutic cannabis use motives. Psychiatric Clinics of North America, 45(3), 503–514. https://doi.org/10.1016/j.psc.2022.05.010
Li, S., Solmi, M., Myran, D. T., & Fabiano, N. (2025). Cannabis and psychosis. CMAJ, 197(29). https://doi.org/10.1503/cmaj.250659
Lima, M. G., Tardelli, V. S., & Fidalgo, T. M. (2024). Contingency management for cannabis use disorder treatment: A systematic review and meta-analysis. European Addiction Research, 30(5), 321–332. https://doi.org/10.1159/000541351
Myran, D. T., Pugliese, M., Harrison, L. D., Solmi, M., Anderson, K. K., Fiedorowicz, J. G., Finkelstein, Y., Manuel, D., Taljaard, M., Webber, C., & Tanuseputro, P. (2025). Changes in incident schizophrenia diagnoses associated with cannabis use disorder after cannabis legalization. JAMA Network Open, 8(2), e2457868. https://doi.org/10.1001/jamanetworkopen.2024.57868
Ryan, J. E., Herens, A., Fruchtman, M., Veliz, P., Kelly, E. L., & Worster, B. (2026). Cannabis use in a community-based sample of adults diagnosed with ADHD: Prevalence, impact on symptoms, and stimulant side effects. Journal of Attention Disorders, 30(3), 407–422. https://doi.org/10.1177/10870547251364575
Schuster, R. M., Costello, M. A., Potter, K., Torquati, M., Gilman, J. M., & Evins, A. E. (2025). Neurocognitive outcomes in adolescents with and without four weeks of cannabis abstinence: A randomized clinical trial using contingency management. Frontiers in Psychiatry, 16, 1723633. https://doi.org/10.3389/fpsyt.2025.1723633
Schuster, R. M., Gilman, J., Schoenfeld, D., Evenden, J., Hareli, M., Ulysse, C., Nip, E., Hanly, A., Zhang, H., & Evins, A. E. (2018). One month of cannabis abstinence in adolescents and young adults is associated with improved memory. Journal of Clinical Psychiatry, 79(6), 17m11977. https://doi.org/10.4088/JCP.17m11977
